Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.28 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.28 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.28 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.28 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.272ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.272ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.272ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.272NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.371ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.371ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.371ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.371NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
AA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.1.353ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.353ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.353ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.353NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.407ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.407ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.407ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.407NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AA.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AA.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
B.1.160.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.47ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15038.3France
B.1.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.182ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.182ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.182NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.218ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.218ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.218ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.218NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.12.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.12.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.12.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used